MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

被引:30
作者
Janes, Holly [1 ,2 ]
Frahm, Nicole [1 ,3 ]
DeCamp, Allan [1 ]
Rolland, Morgane [4 ]
Gabriel, Erin [2 ]
Wolfson, Julian [5 ]
Hertz, Tomer [1 ]
Kallas, Esper [6 ]
Goepfert, Paul [7 ]
Friedrich, David P. [1 ]
Corey, Lawrence [1 ,8 ]
Mullins, James I. [9 ]
McElrath, M. Juliana [1 ,8 ]
Gilbert, Peter [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, Seattle, WA 98104 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[4] US Mil HIV Res Program MHRP, Rockville, MD USA
[5] Univ Minnesota, Div Biostat, Minneapolis, MN USA
[6] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[7] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[8] Univ Washington, Dept Med, Seattle, WA USA
[9] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
来源
PLOS ONE | 2012年 / 7卷 / 08期
关键词
FALSE DISCOVERY RATE; MEDIATED-IMMUNITY; STEP; GAG; EPITOPES; ESCAPE; CTL;
D O I
10.1371/journal.pone.0043396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. Methods: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. Findings: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0.04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0.06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0.04; Pol p = 0.13; Gag p = 0.89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p. 0.50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4.7 vs 5.1) but the difference was not significant (p = 0.27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0.30). Interpretation: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection
    Janes, Holly
    Friedrich, David P.
    Krambrink, Amy
    Smith, Rebecca J.
    Kallas, Esper G.
    Horton, Helen
    Casimiro, Danilo R.
    Carrington, Mary
    Geraghty, Daniel E.
    Gilbert, Peter B.
    McElrath, M. Juliana
    Frahm, Nicole
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (08) : 1231 - 1239
  • [2] HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1
    Hertz, Tomer
    Ahmed, Hasan
    Friedrich, David P.
    Casimiro, Danilo R.
    Self, Steven G.
    Corey, Lawrence
    McElrath, M. Juliana
    Buchbinder, Susan
    Horton, Helen
    Frahm, Nicole
    Robertson, Michael N.
    Graham, Barney S.
    Gilbert, Peter
    PLOS PATHOGENS, 2013, 9 (06)
  • [3] HLA-II-Associated HIV-1 Adaptation Decreases CD4+ T-Cell Responses in HIV-1 Vaccine Recipients
    Files, Jacob K.
    Sterrett, Sarah
    Henostroza, Sebastian
    Fucile, Christopher
    Maroney, Kevin
    Fram, Tim
    Mallal, Simon
    Kalams, Spyros
    Carlson, Jonathan
    Rosenberg, Alexander
    Erdmann, Nathan
    Bansal, Anju
    Goepfert, Paul A.
    JOURNAL OF VIROLOGY, 2022, 96 (17)
  • [4] A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial
    Hertz, T.
    Logan, M. G.
    Rolland, M.
    Magaret, C. A.
    Rademeyer, C.
    Fiore-Gartland, A.
    Edlefsen, P. T.
    DeCamp, A.
    Ahmed, H.
    Ngandu, N.
    Larsen, B. B.
    Frahm, N.
    Marais, J.
    Thebus, R.
    Geraghty, D.
    Hural, J.
    Corey, L.
    Kublin, J.
    Gray, G.
    McElrath, M. J.
    Mullins, J. I.
    Gilbert, P. B.
    Williamson, C.
    VACCINE, 2016, 34 (47) : 5792 - 5801
  • [5] Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
    Edlefsen, Paul T.
    Rolland, Morgane
    Hertz, Tomer
    Tovanabutra, Sodsai
    Gartland, Andrew J.
    decamp, Allan C.
    Magaret, Craig A.
    Ahmed, Hasan
    Gottardo, Raphael
    Juraska, Michal
    McCoy, Connor
    Larsen, Brendan B.
    Sanders-Buell, Eric
    Carrico, Chris
    Menis, Sergey
    Bose, Meera
    Arroyo, Miguel A.
    O'Connell, Robert J.
    Nitayaphan, Sorachai
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Rerks-Ngarm, Supachai
    Robb, Merlin L.
    Kirys, Tatsiana
    Georgiev, Ivelin S.
    Kwong, Peter D.
    Scheffler, Konrad
    Pond, Sergei L. Kosakovsky
    Carlson, Jonathan M.
    Michael, Nelson L.
    Schief, William R.
    Mullins, James I.
    Kim, Jerome H.
    Gilbert, Peter B.
    PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (02)
  • [6] Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity
    Tongo, Marcel
    Burgers, Wendy A.
    VIRUSES-BASEL, 2014, 6 (10): : 3968 - 3990
  • [7] Assessment of the population coverage of an HIV-1 vaccine targeting sequences surrounding the viral protease cleavage sites in Gag, Pol, or all 12 protease cleavage sites
    Daniel, Mathew
    Liang, Binhua
    Luo, Ma
    VACCINE, 2021, 39 (19) : 2676 - 2683
  • [8] Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study
    Li, Fusheng
    Finnefrock, Adam C.
    Dubey, Sheri A.
    Korber, Bette T. M.
    Szinger, James
    Cole, Suzanne
    McElrath, M. Juliana
    Shiver, John W.
    Casimiro, Danilo R.
    Corey, Lawrence
    Self, Steven G.
    PLOS ONE, 2011, 6 (06):
  • [9] Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
    Zolla-Pazner, Susan
    deCamp, Allan
    Gilbert, Peter B.
    Williams, Constance
    Yates, Nicole L.
    Williams, William T.
    Howington, Robert
    Fong, Youyi
    Morris, Daryl E.
    Soderberg, Kelly A.
    Irene, Carmela
    Reichman, Charles
    Pinter, Abraham
    Parks, Robert
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Rerks-Ngarm, Supachai
    Nitayaphan, Sorachai
    Andrews, Charla
    O'Connell, Robert J.
    Yang, Zhi-yong
    Nabel, Gary J.
    Kim, Jerome H.
    Michael, Nelson L.
    Montefiori, David C.
    Liao, Hua-Xin
    Haynes, Barton F.
    Tomaras, Georgia D.
    PLOS ONE, 2014, 9 (02):
  • [10] Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B☆58:02
    Leitman, Ellen M.
    Hurst, Jacob
    Mori, Masahiko
    Kublin, James
    Ndung'u, Thumbi
    Walker, Bruce D.
    Carlson, Jonathan
    Gray, Glenda E.
    Matthews, Philippa C.
    Frahm, Nicole
    Goulder, Philip J. R.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (03) : 379 - 389